These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer. Lan F; Yue X; Han L; Shi Z; Yang Y; Pu P; Yao Z; Kang C Int J Oncol; 2012 Feb; 40(2):519-26. PubMed ID: 21956205 [TBL] [Abstract][Full Text] [Related]
29. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes. Locke JM; Da Silva Xavier G; Rutter GA; Harries LW Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056 [TBL] [Abstract][Full Text] [Related]
30. The transcription factor 7 like 2‑binding protein TIP5 activates β‑catenin/transcription factor signaling in hepatocellular carcinoma. Li C; Wu W; Ding H; Li Q; Xie K Mol Med Rep; 2018 Jun; 17(6):7645-7651. PubMed ID: 29620186 [TBL] [Abstract][Full Text] [Related]
31. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5. Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148 [TBL] [Abstract][Full Text] [Related]
32. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Hatzis P; van der Flier LG; van Driel MA; Guryev V; Nielsen F; Denissov S; Nijman IJ; Koster J; Santo EE; Welboren W; Versteeg R; Cuppen E; van de Wetering M; Clevers H; Stunnenberg HG Mol Cell Biol; 2008 Apr; 28(8):2732-44. PubMed ID: 18268006 [TBL] [Abstract][Full Text] [Related]
33. Transcription factor-associated combinatorial epigenetic pattern reveals higher transcriptional activity of TCF7L2-regulated intragenic enhancers. Liu Q; Bonneville R; Li T; Jin VX BMC Genomics; 2017 May; 18(1):375. PubMed ID: 28499350 [TBL] [Abstract][Full Text] [Related]
34. Statistics of protein-DNA binding and the total number of binding sites for a transcription factor in the mammalian genome. Kuznetsov VA; Singh O; Jenjaroenpun P BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S12. PubMed ID: 20158869 [TBL] [Abstract][Full Text] [Related]
35. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145 [TBL] [Abstract][Full Text] [Related]
36. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver. Oh KJ; Park J; Kim SS; Oh H; Choi CS; Koo SH PLoS Genet; 2012 Sep; 8(9):e1002986. PubMed ID: 23028378 [TBL] [Abstract][Full Text] [Related]
37. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852 [TBL] [Abstract][Full Text] [Related]
38. Mechanistic basis and efficacy of targeting the β-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors. Saenz DT; Fiskus W; Mill CP; Perera D; Manshouri T; Lara BH; Karkhanis V; Sharma S; Horrigan SK; Bose P; Kadia TM; Masarova L; DiNardo CD; Borthakur G; Khoury JD; Takahashi K; Bhaskara S; Lin CY; Green MR; Coarfa C; Crews CM; Verstovsek S; Bhalla KN Blood; 2020 Apr; 135(15):1255-1269. PubMed ID: 32068780 [TBL] [Abstract][Full Text] [Related]
39. Atheroprotective Flow Upregulates ITPR3 (Inositol 1,4,5-Trisphosphate Receptor 3) in Vascular Endothelium via KLF4 (Krüppel-Like Factor 4)-Mediated Histone Modifications. He M; Huang TS; Li S; Hong HC; Chen Z; Martin M; Zhou X; Huang HY; Su SH; Zhang J; Wang WT; Kang J; Huang HD; Zhang J; Chien S; Shyy JY Arterioscler Thromb Vasc Biol; 2019 May; 39(5):902-914. PubMed ID: 30917677 [TBL] [Abstract][Full Text] [Related]
40. Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism. Geoghegan G; Simcox J; Seldin MM; Parnell TJ; Stubben C; Just S; Begaye L; Lusis AJ; Villanueva CJ Mol Metab; 2019 Jun; 24():44-63. PubMed ID: 30948248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]